All Stories

  1. Smart Magnetic Drug Delivery System for Targeted, Intracellular Delivery of Irinotecan and Platinum-Based Antitumoral Drugs
  2. Precision RNA interference of Smad3 and Runx2 via dual targeting nanocarriers mitigates aortic valve disease
  3. Targeting Insulin Resistance in Hepatocytes: A Novel Insulin-Mimetic Agent Delivered via an Advanced Nanocarrier System
  4. Nanocarrier-driven dual targeting VCAM-1/Collagen IV enables RNA interference-mediated silencing of Smad3 and Runx2 to mitigate aortic valve disease
  5. Inflammation resolution-based treatment of atherosclerosis using biomimetic nanocarriers loaded with specialized pro-resolving lipid mediators
  6. Nanotherapeutic Strategies to Reduce Vascular Inflammation in Cardiovascular Diseases
  7. Advances in Natural and Bio-Inspired Nanoparticles for the Treatment of Cardiovascular Diseases
  8. Tri-Component Hydrogel as Template for Nanocrystalline Hydroxyapatite Deposition Using Alternate Soaking Method for Bone Tissue Engineering Applications
  9. Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
  10. Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease
  11. Multilayer gold nanoparticles as non-viral vectors for targeting MCF-7 cancer cells
  12. Chemical Attachment of 5-Nitrosalicylaldimine Motif to Silatrane Resulting in an Organic–Inorganic Structure with High Medicinal Significance
  13. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor
  14. Antitumor Properties of a New Macrocyclic Tetranuclear Oxidovanadium(V) Complex with 3-Methoxysalicylidenvaline Ligand
  15. Bio-Responsive Carriers for Controlled Delivery of Doxorubicin to Cancer Cells
  16. VCAM-1 Targeted Lipopolyplexes as Vehicles for Efficient Delivery of shRNA-Runx2 to Osteoblast-Differentiated Valvular Interstitial Cells; Implications in Calcific Valve Disease Treatment
  17. Double cross-linked pectin beads stable in physiological environment as potential support for biomedical applications
  18. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation
  19. Development of Dextran-Coated Magnetic Nanoparticles Loaded with Protocatechuic Acid for Vascular Inflammation Therapy
  20. A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells
  21. Alginate/poloxamer hydrogel obtained by thiol-acrylate photopolymerization for the alleviation of the inflammatory response of human keratinocytes
  22. Synthesis, Characterization, and In Vitro Insulin-Mimetic Activity Evaluation of Valine Schiff Base Coordination Compounds of Oxidovanadium(V)
  23. Detection of Vascular Reactive Oxygen Species in Experimental Atherosclerosis by High‐Resolution Near‐Infrared Fluorescence Imaging Using VCAM‐1‐Targeted Liposomes Entrapping a Fluorogenic Redox‐Sensitive Probe
  24. A new sponge-type hydrogel based on hyaluronic acid and poly(methylvinylether-alt-maleic acid) as a 3D platform for tumor cell growth
  25. Evaluation of VCAM-1 Targeted Naringenin/Indocyanine Green-Loaded Lipid Nanoemulsions as Theranostic Nanoplatforms in Inflammation
  26. Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells
  27. Functional Role of VCAM-1 Targeted Flavonoid-Loaded Lipid Nanoemulsions in Reducing Endothelium Inflammation
  28. Drug Delivery Platforms for Cardiovascular Applications Based on Alginate-Based Hollow Structures
  29. Smart Alginate-Based Magnetic Platforms for Drug Delivery
  30. The impact of photocatalytic Ag/TiO2 and Ag/N-TiO2 nanoparticles on human keratinocytes and epithelial lung cells
  31. Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells
  32. Squalene/polyethylenimine based non-viral vectors: synthesis and use in systems for sustained gene release
  33. Monocyte/macrophages inflammation is inhibited by a Gi-protein inhibitor encapsulated in liposomes
  34. Biopolymers/poly(ε-caprolactone)/polyethylenimine functionalized nano-hydroxyapatite hybrid cryogel: Synthesis, characterization and application in gene delivery
  35. Emerging Nanocarriers-based Approaches to Diagnose and Red uce Vascular Inflammation in Atherosclerosis
  36. Transfection-capable polycationic nanovectors which include PEGylated-cyclodextrin structural units: a new synthesis pathway
  37. Amendment of the cytokine profile in macrophages subsequent to their interaction with smooth muscle cells: Differential modulation by fractalkine and resistin
  38. Cross-talk between macrophages and smooth muscle cells impairs collagen and metalloprotease synthesis and promotes angiogenesis
  39. Conjugation of curcumin-loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells
  40. P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation
  41. Dynameric Frameworks for DNA Transfection
  42. Inhibition of chemokine receptor CCR2 reduces sarcoma cell transendothelial migration and metastasis to the lungs
  43. Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis
  44. Hybrid fullerene conjugates as vectors for DNA cell-delivery
  45. Flexible cyclic siloxane core enhances the transfection efficiency of polyethylenimine-based non-viral gene vectors
  46. VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes
  47. Functional analysis of the fractalkine gene promoter in human aortic smooth muscle cells exposed to proinflammatory conditions
  48. Subendothelial resistin enhances monocyte transmigration in a co-culture of human endothelial and smooth muscle cells by mechanisms involving fractalkine, MCP-1 and activation of TLR4 and Gi/o proteins signaling
  49. Erratum to “Monocytes and smooth muscle cells cross‐talk activates STAT3 and induces resistin and reactive oxygen species production”
  50. Heparin-Anthranoid Conjugates Associated with Nanomagnetite Particles and Their Cytotoxic Effect on Cancer Cells
  51. Development of curcumin-loaded poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles as anti-inflammatory carriers to human-activated endothelial cells
  52. Monocytes and smooth muscle cells cross-talk activates STAT3 and induces resistin and reactive oxygen species and production
  53. Stem Cell Regenerative Potential Combined with Nanotechnology and Tissue Engineering for Myocardial Regeneration
  54. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways
  55. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: Up-regulation of SOCS3 expression through STAT3 activation
  56. Resistin and High Glucose Concentrations-Activation of Human Smooth Muscle Cells Induces Enhanced Monocyte Chemotaxis
  57. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules
  58. Curcumin and a Morus alba Extract Reduce Pro‐Inflammatory Effects of Resistin in Human Endothelial Cells
  59. High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-kB-dependent mechanisms; the modulating effect of insulin
  60. Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells
  61. Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia
  62. Resistin up-regulates fractalkine expression in human endothelial cells: Lack of additive effect with TNF-α
  63. High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells
  64. Enoxaparin Reduces H<sub>2</sub>O<sub>2</sub>-Induced Activation of Human Endothelial Cells by a Mechanism Involving Cell Adhesion Molecules and Nuclear Transcription Factors
  65. Aspirin and PPAR-α activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells
  66. Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery
  67. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells
  68. Superoxide dismutase entrapped-liposomes restore the impaired endothelium-dependent relaxation of resistance arteries in experimental diabetes
  69. Effect of enoxaparin on high glucose-induced activation of endothelial cells
  70. Designing of ?intelligent? liposomes for efficient delivery of drugs
  71. Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells
  72. A Novel Attribute of Enoxaparin: Inhibition of Monocyte Adhesion to Endothelial Cells by a Mechanism Involving Cell Adhesion Molecules
  73. High Glucose Induces Enhanced Monocyte Adhesion to Valvular Endothelial Cells Via a Mechanism Involving ICAM-1, VCAM-1 and CD18